Codex Capital, L.L.C. Eli Lilly & CO Transaction History
Codex Capital, L.L.C.
- $205 Billion
- Q1 2024
A detailed history of Codex Capital, L.L.C. transactions in Eli Lilly & CO stock. As of the latest transaction made, Codex Capital, L.L.C. holds 17,000 shares of LLY stock, worth $13.8 Million. This represents 6.45% of its overall portfolio holdings.
Number of Shares
17,000
Previous 18,000
5.56%
Holding current value
$13.8 Million
Previous $10.5 Billion
26.04%
% of portfolio
6.45%
Previous 6.12%
Shares
6 transactions
Others Institutions Holding LLY
# of Institutions
4,009Shares Held
752MCall Options Held
8.27MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$78.8 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$60 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$53.6 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$41.8 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$27.5 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $773B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...